Programmed death-ligand 1 expression and its correlation with clinicopathological parameters in gallbladder cancer
Background Immunomodulatory therapies targeting the interaction between programmed cell death protein 1 and programmed death-ligand 1 (PD-L1) have become increasingly important in anticancer treatment. Previous research on the subject of this immune response has established an association with tumor...
Main Authors: | Ji Hye Kim, Kyungbin Kim, Misung Kim, Young Min Kim, Jae Hee Suh, Hee Jeong Cha, Hye Jeong Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology
2020-03-01
|
Series: | Journal of Pathology and Translational Medicine |
Subjects: | |
Online Access: | http://jpatholtm.org/upload/pdf/jptm-2019-11-13.pdf |
Similar Items
-
Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer
by: Thomas Albrecht, et al.
Published: (2021-04-01) -
Localized Adenomyomatosis of Gallbladder Mimicking Advanced Hepatic Flexure Colon Cancer: A Case Report
by: Pae Sun Suh, et al.
Published: (2018-11-01) -
Recent Updates on Diagnosis, Treatment, and Follow-up of Gallbladder Polyps
by: Sung Ill Jang, et al.
Published: (2020-09-01) -
Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
by: Min su You, et al.
Published: (2019-01-01) -
Gallbladder polyps: evolving approach to the diagnosis and management
by: Kook Hyun Kim
Published: (2021-01-01)